Niva Bupa Health Insurance Company Limited has informed the Exchange regarding a press release dated May 08, 2026, titled "Press Release-Audited financial results for the quarter and financial year ended March 31, 2026.".
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.0 pts more than Nifty Smallcap 250 and 3.0 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Niva Bupa Health Insurance reported strong FY26 results with IFRS PAT of ₹366 crore, an 80% jump from the previous year, driven by scale efficiencies and improved operating performance. Gross Written Premium grew 27% year-on-year to ₹8,586 crore (with 1/n), while Q4FY26 GWP stood at ₹2,880 crore with 39% growth. The company gained market share, reaching 10.1% in the retail health segment (76 basis points increase), and improved its Claim Settlement Ratio to 94.4%. The Combined Insurance Service Ratio improved to 101.4% for FY26, with Q4FY26 at 97.4%, showing clear progress toward underwriting profitability.
The 80% PAT growth and 27% revenue growth signal strong operational execution and improving profitability trajectory, which should be positive for the stock. The improving CISR indicates the company is on path to sustainable profitability, addressing previous concerns about underwriting losses.